Hochschulschrift
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
- Alternative title
-
Alzheimer Krankheit: Amyloid Oligomere, therapeutische Agentien, ihre Angriffsziele und Wirkmechanismus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Marburg, Philipps-Universität Marburg, Diss., 2013
- Keyword
-
Morbus Alzheimer, Amyloid beta, Oligomere, Antikörper, Nichtsteroidales Antiphlogistikum
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Event
-
Veröffentlichung
- (where)
-
Marburg
- (who)
-
Philipps-Universität Marburg
- (when)
-
2013
- Creator
- Contributor
-
Bacher, Michael
- URN
-
urn:nbn:de:hebis:04-z2013-00078
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.03.2024, 7:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Balakrishnan, Karthikeyan
- Bacher, Michael
- Philipps-Universität Marburg
Time of origin
- 2013
Other Objects (12)
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Alzheimer disease : therapeutic strategies
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Alzheimer disease : therapeutic strategies
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit
Characterization of high-density prion protein oligomers in rapid progressive and sporadic Alzheimer’s disease
Alzheimer's disease: amyloid oligomers, therapeutic agents, their targets, and mode of action
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Alzheimer disease : therapeutic strategies
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer's disease related oligomers
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Die cerebrale Amyloid-Angiopathie der Alzheimer-Krankheit